Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Exclusion Criteria

• •Lack of prior treatment with an antidepressant during the current depressive episode
• •Participants who report treatment with adjunctive or monotherapy antipsychotic treatment during the current depressive episode.
• •Participants experiencing hallucinations, delusions or any psychotic symptomatology in the current depressive episode
• •Participants with epilepsy or significant history of seizure disorders
• •Participants with a clinically significant current diagnosis of borderline, antisocial, paranoid, schizoid, schizotypal or histrionic personality disorder
• •Participants who have received electroconvulsive therapy (ECT) in the last 10 years.